NCT05451927已完成不适用
A Randomized Double Blind Study to Examine the Effect of Natural Anti-obesity Agent Among Women of Lahore
Hafiza Aisha Sadiqa2 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2022年10月27日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 72
- 试验地点
- 2
- 主要终点
- Body weight
研究概览
简要总结
This double-blind randomized placebo-controlled trial will test the hypothesis that administration of Phaseolus Vulgaris supplementation to women in Lahore, Pakistan, who are overweight will induce the weight loss (Primary outcome) and changes in body composition (Waist circumference) secondary outcome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 45 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •BMI ranges from 25-40
- •Consistently stable body weight for at least 6 months
- •Good general health
- •No ongoing drug treatment for weight reduction
- •Commitment to avoid any changes in lifestyle throughout the test period
- •Age between 18-45 years
- •Women resident of Lahore
排除标准
- •Pregnant or breast-feeding females
- •People with Type 2 diabetes
- •People with any other chronic diseases
- •Weight reduction treatment during the 6 months prior to the study
研究组 & 干预措施
Placebo
Placebo Comparator
Three oral doses of Placebo daily for 3 months
干预措施: Placebo (Dietary Supplement)
Phaseolus Vulgaris
Experimental
Three oral doses of 1000 mg Phaseolus Vulgaris daily for 3 months
干预措施: Phaseolus Vulgaris (Dietary Supplement)
结局指标
主要结局
Body weight
时间窗: 3 months
change in body weight
次要结局
未报告次要终点
研究者
Hafiza Aisha Sadiqa
Student
University of the Punjab
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
A study to measure markers in the breath of patients with Chronic Obstructive Pulmonary Disease (COPD)Respiratory - Chronic obstructive pulmonary diseaseChronic Obstructive Pulmonary DiseaseACTRN12614000617662ung Institute of Western Australia200
进行中（未招募）
1 期
Effect of testosterone in male patients on regular hemodialysisHypogonadal males undergoing hemodialysis (HD).EUCTR2011-005439-20-SEDept of Renal medicine40
进行中（未招募）
不适用
A randomised, double-blind study to assess the efficacy and safety of prophylactis use of maribavir versus oral ganciclovir for the prevention of cytomegalovirus disease in recipients of orthotopic liver transplants - NDPatient undergone to orthotopic liver transplantsMedDRA version: 9.1Level: LLTClassification code 10011831Term: Cytomegalovirus infectionEUCTR2007-004729-16-ITVIROPHARMA INCORPORATED348
进行中（未招募）
1 期
Randomised, double-blind study to demonstrate therapeutic equivalence of formoterol fumarate 12µg capsules delivered by Cyclohaler with Foradil in mild to moderate reversible obstructive airways disease.mild to moderate reversible obstructive airways diseaseEUCTR2005-002538-37-GBPharmachemie B.V.30
进行中（未招募）
1 期
A double blind, placebo controlled study to evaluate the safety and immunogenicity of escalating doses of 108 CFU, 109 CFU and 1010 CFU of M04NM11 in patients who have chronic Hepatitis B infection. - Not AvailableChronic hepatitis B virus infectionEUCTR2005-005293-70-GBEmergent Product Development UK Ltd45